Detalles de la búsqueda
1.
High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality.
Arterioscler Thromb Vasc Biol
; 39(5): 925-933, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917679
2.
Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
Eur Heart J
; 40(32): 2713-2723, 2019 08 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292614
3.
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population.
Sci Rep
; 14(1): 11567, 2024 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38773223
4.
The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.
Atherosclerosis
; 287: 16-23, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31181415
Resultados
1 -
4
de 4
1
Próxima >
>>